Josef Rueschoff

Disease-Free Survival According to Degree of <i>HER2</i> Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial

Mitch Dowsett, Marion Procter, Worta McCaskill‐Stevens et al. · Journal of Clinical Oncology · 2009 · 185 citations · Full text

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer – Differential treatment strategies for subtypes of early gastroesophageal cancer

Manfred P. Lutz, John Zalcberg, Michel Ducreux et al. · European Journal of Cancer · 2012 · 152 citations · Full text

Surgical Oncology, Esophagus, Esophageal Cancer +9

Genotype-Phenotype Comparison of German <i>MLH1</i> and <i>MSH2</i> Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC Consortium

Timm O. Goecke, Karsten Schulmann, Christoph Engel et al. · Journal of Clinical Oncology · 2006 · 151 citations · Full text

Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma

Steven M. Anderson, Kenneth J. Bloom, Dino U. Vallera et al. · Archives of Pathology & Laboratory Medicine · 2012 · 138 citations · Full text

Frequent microsatellite instability in sporadic tumors of the upper urinary tract.

Arndt Hartmann, Livia Zanardo, Tina Bocker Edmonston et al. · PubMed · 2002 · 125 citations

Frequent Microsatellite Instability, Urology, Tumoral Pathology +13